{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:36:06Z","timestamp":1794512166637,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973506"],"award-info":[{"award-number":["81973506"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adipose tissue-derived adipokines are involved in various crosstalk between adipose tissue and other organs. Omentin1, a novel adipokine, exerts vital roles in the maintenance of body metabolism, insulin resistance and the like. However, the protective effect of omentin1 in myocardial ischemia (MI)-induced heart failure (HF) and its specific mechanism remains unclear and to be elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The model of MI-induced HF mice and oxygen glucose deprivation (OGD)-injured cardiomyocytes were performed. Mice with overexpression of omentin1 were constructed by a fat-specific adeno-associated virus (AAV) vector system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We demonstrated that circulating omentin1 level diminished in HF patients compared with healthy subjects. Furthermore, the fat-specific overexpression of omentin1 ameliorated cardiac function, cardiac hypertrophy, infarct size and cardiac pathological features, and also enhanced SIRT3\/FOXO3a signaling in HF mice. Additionally, administration with AAV-omentin1 increased mitochondrial fusion and decreased mitochondrial fission in HF mice, as evidenced by up-regulated expression of Mfn2 and OPA1, and downregulation of p-Drp1(Ser616). Then, it also promoted PINK1\/Parkin-dependent mitophagy. Simultaneously, treatment with recombinant omentin1 strengthened OGD-injured cardiomyocyte viability, restrained LDH release, and enhanced the mitochondrial accumulation of SIRT3 and nucleus transduction of FOXO3a. Besides, omentin1 also ameliorated unbalanced mitochondrial fusion-fission dynamics and activated mitophagy, thereby, improving the damaged mitochondria morphology and controlling mitochondrial quality in OGD-injured cardiomyocytes. Interestingly, SIRT3 played an important role in the improvement effects of omentin1 on mitochondrial function, unbalanced mitochondrial fusion-fission dynamics and mitophagy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Omentin1 improves MI-induced HF and myocardial injury by maintaining mitochondrial dynamical homeostasis and activating mitophagy via upregulation of SIRT3\/FOXO3a signaling. This study provides evidence for further application of omentin1 in cardiovascular diseases from the perspective of crosstalk between heart and adipose tissue.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-022-03642-x","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T20:02:41Z","timestamp":1664827361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3\/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy"],"prefix":"10.1186","volume":"20","author":[{"given":"Jingui","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7617-6534","authenticated-orcid":false,"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"3642_CR1","doi-asserted-by":"publisher","first-page":"108185","DOI":"10.1016\/j.pharmthera.2022.108185","volume":"238","author":"H Tsutsui","year":"2022","unstructured":"Tsutsui H. Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines. Pharmacol Ther. 2022;238:108185.","journal-title":"Pharmacol Ther"},{"issue":"20","key":"3642_CR2","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/eurheartj\/ehac088","volume":"43","author":"FW Prinzen","year":"2022","unstructured":"Prinzen FW, Auricchio A, Mullens W, Linde C, Huizar JF. Electrical management of heart failure: from pathophysiology to treatment. Eur Heart J. 2022;43(20):1917\u201327.","journal-title":"Eur Heart J"},{"issue":"11","key":"3642_CR3","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.115.306885","volume":"118","author":"JJ Fuster","year":"2016","unstructured":"Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118(11):1786\u2013807.","journal-title":"Circ Res"},{"issue":"9","key":"3642_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593\u2013606.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"3642_CR5","first-page":"e17347","volume":"13","author":"P Bai","year":"2021","unstructured":"Bai P, Abdullah F, Lodi M, Sarhadi M, Dilip A, Shahab S, et al. Association between coronary artery disease and plasma omentin-1 levels. Cureus. 2021;13(8):e17347.","journal-title":"Cureus"},{"key":"3642_CR6","doi-asserted-by":"publisher","first-page":"736245","DOI":"10.3389\/fphys.2021.736245","volume":"12","author":"RM Agra-Bermejo","year":"2021","unstructured":"Agra-Bermejo RM, Cacho-Antonio C, Gonzalez-Babarro E, Rozados-Luis A, Couselo-Seijas M, G\u00f3mez-Otero I, et al. A new biomarker tool for risk stratification in \u201cde novo\u201d acute heart failure (OROME). Front Physiol. 2021;12:736245.","journal-title":"Front Physiol"},{"issue":"24","key":"3642_CR7","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.jacc.2014.03.032","volume":"63","author":"Y Kataoka","year":"2014","unstructured":"Kataoka Y, Shibata R, Ohashi K, Kambara T, Enomoto T, Uemura Y, et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J Am Coll Cardiol. 2014;63(24):2722\u201333.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3642_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/JME-20-0236","volume":"66","author":"Z Jin","year":"2021","unstructured":"Jin Z, Xia F, Dong J, Lin T, Cai Y, Chen J, et al. Omentin-1 attenuates glucocorticoid-induced cardiac injury by phosphorylating GSK3\u03b2. J Mol Endocrinol. 2021;66(4):273\u201383.","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"3642_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2015.01.032","volume":"457","author":"K Kazama","year":"2015","unstructured":"Kazama K, Okada M, Yamawaki H. Adipocytokine, omentin inhibits doxorubicin-induced H9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species. Biochem Biophys Res Commun. 2015;457(4):602\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3642_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1515\/cclm-2017-0282","volume":"56","author":"T Xu","year":"2018","unstructured":"Xu T, Zuo P, Wang Y, Gao Z, Ke K. Serum omentin-1 is a novel biomarker for predicting the functional outcome of acute ischemic stroke patients. Clin Chem Lab Med. 2018;56(2):350\u20135.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"3642_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/jim-2021-002071","volume":"70","author":"S Cetin Sanlialp","year":"2022","unstructured":"Cetin Sanlialp S, Nar G, Nar R. Relationship between circulating serum omentin-1 levels and nascent metabolic syndrome in patients with hypertension. J Investig Med. 2022;70(3):780\u20135.","journal-title":"J Investig Med"},{"issue":"1","key":"3642_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-021-01337-z","volume":"20","author":"A Tuttolomondo","year":"2021","unstructured":"Tuttolomondo A, Del Cuore A, La Malfa A, Casuccio A, Daidone M, Maida CD, et al. Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction. Cardiovasc Diabetol. 2021;20(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3642_CR13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2337\/db06-1506","volume":"56","author":"CM de Souza Batista","year":"2007","unstructured":"de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56(6):1655\u201361.","journal-title":"Diabetes"},{"issue":"3","key":"3642_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/14728222.2022.2037556","volume":"26","author":"A Zhao","year":"2022","unstructured":"Zhao A, Xiao H, Zhu Y, Liu S, Zhang S, Yang Z, et al. Omentin-1: a newly discovered warrior against metabolic related diseases. Expert Opin Ther Targets. 2022;26(3):275\u201389.","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"3642_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00125-019-05017-2","volume":"63","author":"C Niersmann","year":"2020","unstructured":"Niersmann C, Maren CK, Maalmi H, Holleczek B, Roden M, Brenner H, et al. Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes. Diabetologia. 2020;63(2):410\u20138.","journal-title":"Diabetologia"},{"key":"3642_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2016.06.003","volume":"251","author":"J Menzel","year":"2016","unstructured":"Menzel J, Romina DG, Biemann R, Wittenbecher C, Aleksandrova K, Pischon T, et al. Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study. Atherosclerosis. 2016;251:415\u201321.","journal-title":"Atherosclerosis"},{"issue":"10","key":"3642_CR17","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1111\/bph.15068","volume":"178","author":"M Forte","year":"2021","unstructured":"Forte M, Schirone L, Ameri P, Basso C, Catalucci D, Modica J, et al. The role of mitochondrial dynamics in cardiovascular diseases. Br J Pharmacol. 2021;178(10):2060\u201376.","journal-title":"Br J Pharmacol"},{"key":"3642_CR18","doi-asserted-by":"publisher","first-page":"100822","DOI":"10.1016\/j.mam.2019.09.006","volume":"71","author":"PE Morales","year":"2020","unstructured":"Morales PE, Arias-Dur\u00e1n C, \u00c1valos-Guajardo Y, Aedo G, Verdejo HE, Parra V, et al. Emerging role of mitophagy in cardiovascular physiology and pathology. Mol Aspects Med. 2020;71:100822.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"3642_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, et al. Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14(4):238\u201350.","journal-title":"Nat Rev Cardiol"},{"key":"3642_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105802","volume":"172","author":"C Wang","year":"2021","unstructured":"Wang C, Wang Y, Shen L. Mitochondrial proteins in heart failure: the role of deacetylation by SIRT3. Pharmacol Res. 2021;172: 105802.","journal-title":"Pharmacol Res"},{"key":"3642_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2018.09.009","volume":"53","author":"J Liu","year":"2019","unstructured":"Liu J, Yan W, Zhao X, Jia Q, Wang J, Zhang H, et al. Sirt3 attenuates post-infarction cardiac injury via inhibiting mitochondrial fission and normalization of AMPK-Drp1 pathways. Cell Signal. 2019;53:1\u201313.","journal-title":"Cell Signal"},{"issue":"17","key":"3642_CR22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/ars.2018.7703","volume":"31","author":"A Benigni","year":"2019","unstructured":"Benigni A, Cassis P, Conti S, Perico L, Corna D, Cerullo D, et al. Sirt3 deficiency shortens life span and impairs cardiac mitochondrial function rescued by Opa1 gene transfer. Antioxid Redox Signal. 2019;31(17):1255\u201371.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"3642_CR23","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1002\/jcp.27329","volume":"234","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Shi B, Ma M, Wu X, Lin X. The novel relationship between Sirt3 and autophagy in myocardial ischemia-reperfusion. J Cell Physiol. 2019;234(5):5488\u201395.","journal-title":"J Cell Physiol"},{"issue":"8","key":"3642_CR24","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.bbadis.2016.10.021","volume":"1863","author":"W Yu","year":"2017","unstructured":"Yu W, Gao B, Li N, Wang J, Qiu C, Zhang G, et al. Sirt3 deficiency exacerbates diabetic cardiac dysfunction: role of foxo3a-parkin-mediated mitophagy. Biochim Biophys Acta Mol Basis Dis. 2017;1863(8):1973\u201383.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"8","key":"3642_CR25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41401-021-00830-1","volume":"43","author":"Q Lai","year":"2022","unstructured":"Lai Q, Liu FM, Rao WL, Yuan GY, Fan ZY, Zhang L, et al. Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure. Acta Pharmacol Sin. 2022;43(8):2003\u201315.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"3642_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrcardio.2011.154","volume":"8","author":"O Gjesdal","year":"2011","unstructured":"Gjesdal O, Bluemke DA, Lima JA. Cardiac remodeling at the population level\u2013risk factors, screening, and outcomes. Nat Rev Cardiol. 2011;8(12):673\u201385.","journal-title":"Nat Rev Cardiol"},{"key":"3642_CR27","doi-asserted-by":"publisher","first-page":"118083","DOI":"10.1016\/j.lfs.2020.118083","volume":"257","author":"Q Yin","year":"2020","unstructured":"Yin Q, Zhao B, Zhu J, Fei Y, Shen W, Liang B, et al. JLX001 improves myocardial ischemia-reperfusion injury by activating Jak2-Stat3 pathway. Life Sci. 2020;257:118083.","journal-title":"Life Sci"},{"issue":"19","key":"3642_CR28","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1111\/bph.14781","volume":"176","author":"CC Hsieh","year":"2019","unstructured":"Hsieh CC, Li CY, Hsu CH, Chen HL, Chen YH, Liu YP, et al. Mitochondrial protection by simvastatin against angiotensin II-mediated heart failure. Br J Pharmacol. 2019;176(19):3791\u2013804.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"3642_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41401-020-0377-7","volume":"41","author":"Q Lai","year":"2020","unstructured":"Lai Q, Yuan GY, Wang H, Liu ZL, Kou JP, Yu BY, et al. Exploring the protective effects of schizandrol A in acute myocardial ischemia mice by comprehensive metabolomics profiling integrated with molecular mechanism studies. Acta Pharmacol Sin. 2020;41(8):1058\u201372.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"3642_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1152\/ajpcell.00462.2010","volume":"300","author":"KW Dunn","year":"2011","unstructured":"Dunn KW, Kamocka MM, McDonald JH. A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol. 2011;300(4):723\u201342.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"3642_CR31","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijms20092358","volume":"20","author":"M Longo","year":"2019","unstructured":"Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20(9):2358.","journal-title":"Int J Mol Sci"},{"key":"3642_CR32","doi-asserted-by":"publisher","first-page":"583175","DOI":"10.3389\/fcvm.2020.583175","volume":"7","author":"AE Berezin","year":"2020","unstructured":"Berezin AE, Berezin AA, Lichtenauer M. Emerging role of adipocyte dysfunction in inducing heart failure among obese patients with prediabetes and known diabetes mellitus. Front Cardiovasc Med. 2020;7:583175.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"3642_CR33","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.3390\/molecules25112534","volume":"25","author":"NA Binti Kamaruddin","year":"2020","unstructured":"Binti Kamaruddin NA, Fong LY, Tan JJ, Abdullah MNH, Singh Cheema M, Bin Yakop F, et al. Cytoprotective role of omentin against oxidative stress-induced vascular endothelial cells injury. Molecules. 2020;25(11):2534.","journal-title":"Molecules"},{"issue":"20","key":"3642_CR34","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.18632\/aging.102251","volume":"11","author":"F Xu","year":"2019","unstructured":"Xu F, Li FX, Lin X, Zhong JY, Wu F, Shan SK, et al. Adipose tissue-derived omentin-1 attenuates arterial calcification via AMPK\/Akt signaling pathway. Aging (Albany NY). 2019;11(20):8760\u201376.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"3642_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cvr\/cvv282","volume":"110","author":"HI Mizuho","year":"2016","unstructured":"Mizuho HI, Shibata R, Ohashi K, Uemura Y, Kanemura N, Kambara T, et al. Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. Cardiovasc Res. 2016;110(1):107\u201317.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"3642_CR36","first-page":"91","volume":"21","author":"\u00d6 Kutlay","year":"2019","unstructured":"Kutlay \u00d6, Kayg\u0131s\u0131z Z, Kayg\u0131s\u0131z B. Effect of omentin on cardiovascular functions and gene expressions in isolated rat hearts. Anatol J Cardiol. 2019;21(2):91\u20137.","journal-title":"Anatol J Cardiol"},{"issue":"4","key":"3642_CR37","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2010.02.053","volume":"393","author":"H Yamawaki","year":"2010","unstructured":"Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. 2010;393(4):668\u20136672.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3642_CR38","doi-asserted-by":"publisher","first-page":"e12605","DOI":"10.1111\/ijpo.12605","volume":"15","author":"J Rothermel","year":"2020","unstructured":"Rothermel J, Lass N, Barth A, Reinehr T. Link between omentin-1, obesity and insulin resistance in children: Findings from a longitudinal intervention study. Pediatr Obes. 2020;15(5):e12605.","journal-title":"Pediatr Obes"},{"key":"3642_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1475-2840-10-103","volume":"10","author":"HJ Yoo","year":"2011","unstructured":"Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol. 2011;10:103.","journal-title":"Cardiovasc Diabetol"},{"key":"3642_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2015.10.100","volume":"244","author":"CH Saely","year":"2016","unstructured":"Saely CH, Leiherer A, Muendlein A, Vonbank A, Rein P, Geiger K, et al. High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. Atherosclerosis. 2016;244:38\u201343.","journal-title":"Atherosclerosis"},{"issue":"9","key":"3642_CR41","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI120849","volume":"128","author":"B Zhou","year":"2018","unstructured":"Zhou B, Tian R. Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest. 2018;128(9):3716\u201326.","journal-title":"J Clin Invest"},{"issue":"12","key":"3642_CR42","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","volume":"118","author":"E Murphy","year":"2016","unstructured":"Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW II, Kitsis RN, et al. Mitochondrial function, biology, and role in disease a scientific statement from the american heart association. Cir Res. 2016;118(12):1960\u201391.","journal-title":"Cir Res"},{"key":"3642_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","volume":"15","author":"DC Chan","year":"2020","unstructured":"Chan DC. Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol. 2020;15:235\u201359.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"3642_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1042\/EBC20170104","volume":"62","author":"L Tilokani","year":"2018","unstructured":"Tilokani L, Nagashima S, Paupe V, Prudent J. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem. 2018;62(3):341\u201360.","journal-title":"Essays Biochem"},{"key":"3642_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3389\/fphar.2020.01083","volume":"11","author":"L Chen","year":"2020","unstructured":"Chen L, Chen XY, Wang QL, Yang SJ, Zhou H, Ding LS, et al. Astragaloside IV derivative (LS-102) alleviated myocardial ischemia reperfusion injury by inhibiting Drp1(Ser616) Phosphorylation-mediated mitochondrial fission. Front Pharmacol. 2020;11:1083.","journal-title":"Front Pharmacol"},{"key":"3642_CR46","doi-asserted-by":"publisher","first-page":"109147","DOI":"10.1016\/j.abb.2022.109147","volume":"718","author":"J Ding","year":"2022","unstructured":"Ding J, Zhang Z, Li S, Wang W, Du T, Fang Q, et al. Mdivi-1 alleviates cardiac fibrosis post myocardial infarction at infarcted border zone, possibly via inhibition of Drp1-activated mitochondrial fission and oxidative stress. Arch Biochem Biophys. 2022;718:109147.","journal-title":"Arch Biochem Biophys"},{"key":"3642_CR47","doi-asserted-by":"publisher","first-page":"720085","DOI":"10.3389\/fcvm.2021.720085","volume":"8","author":"J Liu","year":"2021","unstructured":"Liu J, Song X, Yan Y, Liu B. Role of GTPase-dependent mitochondrial dynamins in heart diseases. Front Cardiovasc Med. 2021;8:720085.","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"3642_CR48","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/CIRCRESAHA.111.258723","volume":"109","author":"Y Chen","year":"2011","unstructured":"Chen Y, Liu Y, Dorn GW 2nd. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Cir Res. 2011;109(12):1327\u201331.","journal-title":"Cir Res"},{"issue":"4","key":"3642_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1083\/jcb.201411100","volume":"208","author":"A Mourier","year":"2015","unstructured":"Mourier A, Motori E, Brandt T, Lagouge M, Atanassov I, Galinier A, et al. Mitofusin 2 is required to maintain mitochondrial coenzyme Q levels. J Cell Biol. 2015;208(4):429\u201342.","journal-title":"J Cell Biol"},{"issue":"2","key":"3642_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1091\/mbc.E20-09-0605","volume":"32","author":"R Wang","year":"2021","unstructured":"Wang R, Mishra P, Garbis SD, Moradian A, Sweredoski MJ, Chan DC. Identification of new OPA1 cleavage site reveals that short isoforms regulate mitochondrial fusion. Mol Biol Cell. 2021;32(2):157\u201368.","journal-title":"Mol Biol Cell"},{"issue":"6","key":"3642_CR51","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1083\/jcb.201308006","volume":"204","author":"R Anand","year":"2014","unstructured":"Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol. 2014;204(6):919\u201329.","journal-title":"J Cell Biol"},{"issue":"6265","key":"3642_CR52","doi-asserted-by":"publisher","first-page":"aad0116","DOI":"10.1126\/science.aad0116","volume":"350","author":"T Wai","year":"2015","unstructured":"Wai T, Garc\u00eda-Prieto J, Baker MJ, Merkwirth C, Benit P, Rustin P, et al. Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science. 2015;350(6265):aad0116.","journal-title":"Science"},{"issue":"6","key":"3642_CR53","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.cmet.2015.05.007","volume":"21","author":"T Varanita","year":"2015","unstructured":"Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, et al. The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metab. 2015;21(6):834\u201344.","journal-title":"Cell Metab"},{"issue":"14","key":"3642_CR54","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1093\/cvr\/cvaa340","volume":"117","author":"T Saito","year":"2021","unstructured":"Saito T, Hamano K, Sadoshima J. Molecular mechanisms and clinical implications of multiple forms of mitophagy in the heart. Cardiovasc Res. 2021;117(14):2730\u201341.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3642_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvx201","volume":"114","author":"C Kang","year":"2018","unstructured":"Kang C, Badr MA, Kyrychenko V, Eskelinen EL, Shirokova N. Deficit in PINK1\/PARKIN-mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy. Cardiovasc Res. 2018;114(1):90\u2013102.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"3642_CR56","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.116.303790","volume":"116","author":"T Saito","year":"2015","unstructured":"Saito T, Sadoshima J. Molecular mechanisms of mitochondrial autophagy\/mitophagy in the heart. Circ Res. 2015;116(8):1477\u201390.","journal-title":"Circ Res"},{"key":"3642_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2015.10.005","volume":"156","author":"UA Mukherjee","year":"2015","unstructured":"Mukherjee UA, Ong SB, Ong SG, Hausenloy DJ. Parkinson\u2019s disease proteins: Novel mitochondrial targets for cardioprotection. Pharmacol Ther. 2015;156:34\u201343.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"3642_CR58","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.tips.2017.01.009","volume":"38","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Liu J, Chen D, Yan L, Zheng W. Sirtuin inhibition: strategies, inhibitors, and therapeutic potential. Trends Pharmacol Sci. 2017;38(5):459\u201372.","journal-title":"Trends Pharmacol Sci"},{"key":"3642_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2020.08.021","volume":"179","author":"S Wang","year":"2020","unstructured":"Wang S, Zhang J, Deng X, Zhao Y, Xu K. Advances in characterization of SIRT3 deacetylation targets in mitochondrial function. Biochimie. 2020;179:1\u201313.","journal-title":"Biochimie"},{"issue":"18","key":"3642_CR60","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.7150\/thno.45922","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J, Xiang H, Liu J, Chen Y, He RR, Liu B. Mitochondrial Sirtuin 3: new emerging biological function and therapeutic target. Theranostics. 2020;10(18):8315\u201342.","journal-title":"Theranostics"},{"issue":"4","key":"3642_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-015-0493-6","volume":"110","author":"C Koentges","year":"2015","unstructured":"Koentges C, Pfeil K, Schnick T, Wiese S, Dahlbock R, Cimolai MC, et al. SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic Res Cardiol. 2015;110(4):36.","journal-title":"Basic Res Cardiol"},{"issue":"19","key":"3642_CR62","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.117.030486","volume":"137","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ji R, Liao X, Castillero E, Kennel PJ, Brunjes DL, et al. MicroRNA-195 regulates metabolism in failing myocardium via alterations in sirtuin 3 expression and mitochondrial protein acetylation. Circulation. 2018;137(19):2052\u201367.","journal-title":"Circulation"},{"issue":"9","key":"3642_CR63","first-page":"2758","volume":"119","author":"NR Sundaresan","year":"2009","unstructured":"Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest. 2009;119(9):2758\u201371.","journal-title":"J Clin Invest"},{"key":"3642_CR64","doi-asserted-by":"publisher","first-page":"104626","DOI":"10.1016\/j.phrs.2019.104626","volume":"152","author":"SS Ana","year":"2020","unstructured":"Ana SS, Testai L, Nabavi SF, Battino M, Devi KP, Tejada S, et al. Therapeutic potential of polyphenols in cardiovascular diseases: regulation of mTOR signaling pathway. Pharmacol Res. 2020;152:104626.","journal-title":"Pharmacol Res"},{"issue":"5","key":"3642_CR65","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","volume":"18","author":"M Morita","year":"2013","unstructured":"Morita M, Gravel SP, Ch\u00e9nard V, Sikstr\u00f6m K, Zheng L, Alain T, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab. 2013;18(5):698\u2013711.","journal-title":"Cell Metab"},{"issue":"6","key":"3642_CR66","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2017.08.013","volume":"67","author":"M Morita","year":"2017","unstructured":"Morita M, Prudent J, Basu K, Goyon V, Katsumura S, Hulea L, et al. mTOR controls mitochondrial dynamics and cell survival via MTFP1. Mol Cell. 2017;67(6):922\u201335.","journal-title":"Mol Cell"},{"issue":"18","key":"3642_CR67","doi-asserted-by":"publisher","first-page":"9765","DOI":"10.3390\/ijms22189765","volume":"22","author":"Y Chun","year":"2021","unstructured":"Chun Y, Kim J. AMPK-mTOR signaling and cellular adaptations in hypoxia. Int J Mol Sci. 2021;22(18):9765.","journal-title":"Int J Mol Sci"},{"key":"3642_CR68","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3389\/fphys.2018.01526","volume":"9","author":"W Zhao","year":"2018","unstructured":"Zhao W, Zhang L, Chen R, Lu H, Sui M, Zhu Y, et al. SIRT3 protects against acute kidney injury via AMPK\/mTOR-regulated autophagy. Front Physiol. 2018;9:1526.","journal-title":"Front Physiol"},{"key":"3642_CR69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.freeradbiomed.2017.04.005","volume":"108","author":"SH Dai","year":"2017","unstructured":"Dai SH, Chen T, Li X, Yue KY, Luo P, Yang LK, et al. Sirt3 confers protection against neuronal ischemia by inducing autophagy: involvement of the AMPK-mTOR pathway. Free Radic Biol Med. 2017;108:345\u201353.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"3642_CR70","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1002\/jcp.29727","volume":"235","author":"D Han","year":"2020","unstructured":"Han D, Jiang L, Gu X, Huang S, Pang J, Wu Y, et al. SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK\/mTOR pathway and promoting GPX4 levels. J Cell Physiol. 2020;235(11):8839\u201351.","journal-title":"J Cell Physiol"},{"key":"3642_CR71","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijbiomac.2021.02.029","volume":"175","author":"K Xu","year":"2021","unstructured":"Xu K, He Y, Moqbel SAA, Zhou X, Wu L, Bao J. SIRT3 ameliorates osteoarthritis via regulating chondrocyte autophagy and apoptosis through the PI3K\/Akt\/mTOR pathway. Int J Biol Macromol. 2021;175:351\u201360.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3642_CR72","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.119.315767","volume":"126","author":"AE Dikalova","year":"2020","unstructured":"Dikalova AE, Pandey A, Xiao L, Arslanbaeva L, Sidorova T, Lopez MG, et al. Mitochondrial deacetylase sirt3 reduces vascular dysfunction and hypertension while sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ Res. 2020;126(4):439\u201352.","journal-title":"Circ Res"},{"issue":"1","key":"3642_CR73","doi-asserted-by":"publisher","first-page":"e12686","DOI":"10.1111\/jpi.12686","volume":"70","author":"J Jiang","year":"2021","unstructured":"Jiang J, Liang S, Zhang J, Du Z, Xu Q, Duan J, et al. Melatonin ameliorates PM(2.5) -induced cardiac perivascular fibrosis through regulating mitochondrial redox homeostasis. J Pineal Res. 2021;70(1):e12686.","journal-title":"J Pineal Res."},{"issue":"6","key":"3642_CR74","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s11427-021-1982-8","volume":"65","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Li D, Dong X, Zhang X, Liu J, Peng L, et al. LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy. Sci China Life Sci. 2022;65(6):1198\u2013212.","journal-title":"Sci China Life Sci"},{"issue":"17","key":"3642_CR75","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1089\/scd.2021.0099","volume":"30","author":"JX Chen","year":"2021","unstructured":"Chen JX, Yang L, Sun L, Chen W, Wu J, Zhang CF, et al. Sirtuin 3 Ameliorates lung senescence and improves type ii alveolar epithelial cell function by enhancing the FOXO3a-dependent antioxidant defense mechanism. Stem Cells Dev. 2021;30(17):843\u201355.","journal-title":"Stem Cells Dev"},{"issue":"3","key":"3642_CR76","doi-asserted-by":"publisher","first-page":"e13820","DOI":"10.1111\/jfbc.13820","volume":"46","author":"W Yang","year":"2022","unstructured":"Yang W, Wang Y, Hao Y, Wang Z, Liu J, Wang J. Piceatannol alleviate ROS-mediated PC-12 cells damage and mitochondrial dysfunction through SIRT3\/FOXO3a signaling pathway. J Food Biochem. 2022;46(3):e13820.","journal-title":"J Food Biochem"},{"key":"3642_CR77","doi-asserted-by":"publisher","first-page":"4946711","DOI":"10.1155\/2021\/4946711","volume":"2021","author":"L Chodari","year":"2021","unstructured":"Chodari L, Dilsiz Aytemir M, Vahedi P, Alipour M, Vahed SZ, Khatibi SMH, et al. Targeting mitochondrial biogenesis with polyphenol compounds. Oxid Med Cell Longev. 2021;2021:4946711.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03642-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T21:03:05Z","timestamp":1664830985000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03642-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3642"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03642-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the ethical policies and all experimental procedures were approved by the Animal Ethics Committee of China Pharmaceutical University and the Laboratory Animal Management Committee of Jiangsu Province (Approval No. 220193566). Clinical serum samples were obtained from the Jiangsu Province Hospital of Traditional Chinese Medicine. Informed consent was obtained from all human research participants and this study was guided by the Helsinki Declaration (No. 2019NL-089-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"447"}}